Alzheimer's disease (AD) is an incurable neurodegenerative disease. Better diagnosis of AD is extremely important for therapeutic interventions. The amyloid cascade hypothesis and its revised version identify insoluble β-amyloid deposition as a good diagnostic biomarker for AD. We hypothesize that lysosomal viscosity may also act as an auxiliary biomarker for AD based on literature research. Herein, we have successfully developed a FP chromophore analogue C25 as a dual-functional fluorescent probe which can respond effectively to the Aβ fibrils and enhanced lysosomal viscosity with distinguishable turn-on fluorescence signals around 570 nm and 600 nm, respectively. The probe C25 can also monitor the Aβ degradation in the lysosomes. The probe C25 can serve as a promising tool for developing early diagnosis and innovative therapeutics of AD.
Read full abstract